当前位置:主页 > 医学论文 > 呼吸病论文 >

应用非氟里昂抛射剂的硫酸沙丁胺醇气雾剂治疗支气管哮喘的随机对照临床试验

发布时间:2018-11-10 17:01
【摘要】:目的评价应用非氟里昂抛射剂的国产硫酸沙丁胺醇气雾剂治疗支气管哮喘疗效与安全性。方法以进口硫酸沙丁胺醇气雾剂为阳性对照药,采用多中心、随机、双盲、阳性药物平行对照试验设计,试验组予以单次吸入国产硫酸沙丁胺醇气雾剂,对照组单次吸入进口硫酸沙丁胺醇气雾剂,观察给药后肺功能及症状评分改善情况。结果两组给药后15min,30min,120min,240min第一秒用力呼气容积(FEV1)较给药前均有改善,FEV1增加绝对值在给药后30min达到最大,各个时间点FEV1改善值和改善率组内比较差异有统计学意义(P0.05),组间比较均无统计学意义(P0.05);用力肺活量(FVC)、呼吸困难评分、咳嗽评分、呼气相干音评分等症状体征在用药后各个时间点较用药前均改善且差异有统计学意义(P0.05),组间比较差异无统计学意义(P0.05)。两组用药后不良反应率差异无统计学意义(P0.05),均表现出较好的安全性。结论应用非氟里昂抛射剂的国产硫酸沙丁胺醇气雾剂作为支气管哮喘缓解药物的疗效与安全性均较好。
[Abstract]:Objective to evaluate the efficacy and safety of domestic salbutamol sulfate aerosol in the treatment of bronchial asthma. Methods the imported salbutamol sulfate aerosol was used as a positive control drug. A multicenter, randomized, double-blind, parallel control trial was designed. The experimental group was given a single inhalation of domestic salbutamol sulfate aerosol. The control group inhaled the imported salbutamol sulfate aerosol and observed the improvement of pulmonary function and symptom score. Results the forced expiratory volume (FEV1) in the first second was improved in both groups 15 min after administration and 30 min after administration. The absolute value of FEV1 increased to the maximum after administration. There were significant differences in FEV1 improvement value and improvement rate between groups at each time point (P0.05), but there was no significant difference between groups (P0.05). The symptoms and signs of forced vital capacity (FVC),) dyspnea score, cough score, breath coherence score and so on were improved at each time point after treatment compared with those before medication (P0.05). There was no significant difference between the two groups (P0.05). There was no significant difference in adverse reaction rate between the two groups (P0.05), both showed good safety. Conclusion domestic salbutamol sulfate aerosol with non-Freon ejector is effective and safe for relieving bronchial asthma.
【作者单位】: 四川大学华西医院GCP中心;四川大学华西医院呼吸内科;海南省人民医院呼吸科;河北省人民医院呼吸科;西安交通大学第二附属医院呼吸科;昆明医学院第一附属医院呼吸科;
【分类号】:R562.25

【参考文献】

相关期刊论文 前5条

1 周新;;定量吸入气雾剂的研究进展[J];世界临床药物;2012年11期

2 金方;王彦;;我国吸入气雾剂用氟里昂替代的研究现状和挑战[J];上海医药;2009年04期

3 王平;陈桂良;;我国药用气雾剂CFC替代的现状和思考[J];中国医药工业杂志;2008年11期

4 金方;侯曙光;魏农农;;氟利昂替代后吸入气雾剂(MDIs)的研究要求和进展 Ⅰ.欧美抛射剂替代的MDIs的研发和质量控制[J];中国医药工业杂志;2009年07期

5 侯曙光;魏农农;金方;;氟利昂替代后吸入气雾剂(MDIs)的研究要求和进展Ⅱ.抛射剂替代的MDIs的技术挑战和工业化生产[J];中国医药工业杂志;2009年08期

【共引文献】

相关期刊论文 前8条

1 周新;;定量吸入气雾剂的研究进展[J];世界临床药物;2012年11期

2 王守斌;王博;孙歆慧;王维;任晓文;;吸入制剂的研究进展[J];现代药物与临床;2013年02期

3 闫庆红;单长波;;经气道递送药物[J];临床肺科杂志;2011年02期

4 严翠霞;王麟达;陈桂良;;新一代药用撞击器及其应用[J];药物分析杂志;2009年09期

5 胡天羽;李华;马t,

本文编号:2323041


资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/huxijib/2323041.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户dcb50***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com